Immix Biopharma, Inc. - IMMX Income before deduction of interest, taxes and amortization
Absolute EBITDA correlates with the scientific alliances of Immix Biopharma, Inc. (IMMX) regarding the treatment of rare pathologies. The 0.00 mark reflects fresh data on the company, which is developing CAR-T drugs for oncology clinics to capture the cell therapy market. However, early-stage testing of tissue-specific agents is inflating R&D expenses, keeping the operating leverage in negative territory.
Immix Biopharma - analytical breakdowns and key metrics (IMMX)
- market value and analyst target forecast:
- issuer market value details:
- book capitalization information:
- business debt structure and liquidity details:
- company profitability and valuation multiples indicators:
IMMX - Net Income|Future Net Profit Immix Biopharma, Inc.|IMMX - P/E Multiple|Future Price to Earnings Multiple Immix Biopharma Inc.|IMMX - PEG Multiple|Company Value to EBITDA Immix Biopharma|IMMX - Profit before payment of interest, taxes and amortization|Earnings per share for the trailing year Immix Biopharma|IMMX - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth immixbio.com|IMMX - Earnings per share growth in current year|Net earnings per share change forecast for next year Immix Biopharma, Inc.
Analysis of all company metrics:Immix Biopharma, Inc. - IMMX
This indicator tracks daily cash flow from operating activities, allowing investors to identify hidden liquidity anomalies and avoid purchasing the asset at the peak of a temporary spike. Analysis of EBITDA reflects the ability of Immix Biopharma, Inc. (IMMX) to monetize CAR-T therapy, directly linking cash flow to cell production efficiency and clinical success in treating amyloidosis.
Competitors of Immix Biopharma, Inc. (IMMX)
NantKwest (IBRX) - Profit before interest, taxes and amortization|IMCR: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization JANX (januxrx.com)|RCUS: Operating profit EBITDA|ZYME - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Tango Pharma|Operating profit before deduction of amortization Iovance Corp (IOVA)|Profit before payment of interest, taxes and amortization Immatics N.V. (IMTX)|Operating profit before deduction of amortization xencor.com XNCR|Compass Therapeutics, Inc. - Operating profit before deduction of amortization|Operating profit EBITDA Replimune Group Inc REPL|LYEL - Profit before payment of interest, taxes and amortization|IPHA (Innate Pharma S.A) - Operating profit before amortization|pyxisoncology.com (PYXS) - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization Compugen (CGEN)|Operating profit before deduction of amortization IOBT|STRO - Operating profit before depreciation charges|Operating profit before deduction of amortization INKT (MiNK)|Company profit before taxes, interest and amortization HOWL|Operating profit EBITDA ALXO (ALX Oncology)|Income before deduction of interest, taxes and amortization CUE|PDS Biotechnology Corp - Operating profit EBITDA|Profit before interest, taxes and amortization Sonnet BioTherapeutics|MAIA Biotechnology Inc (MAIA) - Profit before payment of interest, taxes and amortization|Liminatus - Income before deduction of interest, taxes and amortization|LVTX (LAVA Therapeutics NV) - Operating profit EBITDA|Operating profit EBITDA nextcure.com|Profit before payment of interest, taxes and amortization Leap Therapeutics, Inc. (LPTX)|INTS: Profit before deduction of interest, taxes, depreciation and amortization|Sensei Biotherapeutics, Inc. - Operating profit before deduction of amortization|Theriva Corp (TOVX) - Profit before interest, taxes and amortization|Gritstone Bio - Operating profit EBITDA|Operating income before deduction of amortization kinetabio.com KA|NexImmune (NEXI) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization Turnstone Biologics Corp.|Profit before payment of interest, taxes and amortization Vaccinex, Inc|Operating profit before deduction of amortization Harpoon Therapeutics Corp (HARP)
